Intra-Cellular Therapies (ITCI) stock rose more than 35% premarket after Johnson & Johnson (JNJ) agreed to buy the biopharmaceutical company for $132 a share. Read more: ...

Americans will have more opportunities to eat ShackBurgers in coming years, as fast-casual chain Shake Shack plans to more ...

Macy’s warned of weaker revenue in the crucial year-end period, saying net sales will likely come in at the low end or slightly below its previously guided range of $7.8 billion to $8 billion.

Global oil prices are on track to settle at their highest level since August, boosted by the prospect of new sanctions ...